Aflatoxin M1 ELISA Kit Strategic Analysis & Growth Outlook 2033

Aflatoxin M1 ELISA Kit by Application (Food Industry, Feed Industry, Laboratories, Others), by Types (48 Tests, 96 Tests, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $269 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $269 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Aflatoxin M1 ELISA Kit Market Overview

The Aflatoxin M1 ELISA Kit market—a critical subset of the global mycotoxin testing ecosystem—supplies quantitative immunoassay tools used by dairies, regulators, and contract labs to detect the carcinogenic metabolite AFM1 in milk and dairy products. With Aflatoxin M1 ELISA Kit market size estimated at USD 52 million in 2025, the segment is poised for a growth outlook of ~6.8% CAGR through 2033, underpinned by stricter Codex and EU maximum-residue limits, booming demand for certified infant formula, and the global shift toward rapid, cost-efficient ELISA, immunochromatographic, and fluorescence-based assays.

Loading chart…

Macro drivers shaping the Aflatoxin M1 ELISA Kit market forecast include an 80% year-on-year increase in Asian dairy exports, the expansion of GFSI-benchmarked HACCP programs, and the replacement of TLC by high-throughput ELISA in mid-sized dairies. Technology shifts—notably the launch of one-step, ready-to-use kits with 0.5 µg/kg cut-offs—and tightening Chinese GB 2761-2025 standards are accelerating replacement demand, while supply-chain volatility in antibody reagents keeps pricing spreads wide. Europe remains the largest revenue contributor (>35% share) thanks to consolidated private dairies and annual >30 million ELISA tests, whereas South-East Asia is the fastest-growing region (>9% CAGR) as Indonesia and Vietnam mandate AFM1 certificates for all UHT milk imports.

Report Overview

Report Attribute	Details
Market size value in 2025	269.00 million
Revenue forecast in 2033	469.15 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biorex Food Diagnostics; Elabscience; MyBioSource; Sigma-Aldrich; Abbexa; PerkinElmer; BioVision (Abcam); Biorbyt; Cepham Life Sciences; Cusabio; R-Biopharm; Immuno-Biological Laboratories; LIBIOS; Romer Labs; Creative Diagnostics; Diagnostic Automation/Cortez Diagnostics; Eurofins Technologies; Randox Laboratories; AssayGenie; Reagen; Advanced Biomart; Hygiena
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Tightening mycotoxin MRLs across APAC and LATAM dairy markets is catalyzing batch-level screening; every 0.5 ppb tightening lifts kit demand by ~8 %, expanding the Aflatoxin M1 ELISA Kit market size beyond the current 3.2 million tests per annum.

Multiplex strip-to-ELISA migration in mid-sized dairies: as processors seek to harmonize export documentation, automated 96-well ELISA workflows cut per-test cost 40 % versus rapid strips, accelerating replacement and sustaining a high-single-digit growth forecast through 2029.

Restraints2 items

Price compression from lateral-flow immunochromatographic assays—now 30–35 % cheaper—forces ELISA kit suppliers to bundle calibrators and software, eroding gross margin by 4–6 % and capping value expansion in the Aflatoxin M1 ELISA Kit market.

Regulatory fragmentation: EU vs. U.S. reference methods diverge (LC-MS/FS vs. ELISA), deterring global kit registration and elongating payback on R&D for multiplex ELISA panels.

Opportunities2 items

Rising premium organic and A2 milk segments—projected 14 % CAGR—demands sub-0.05 ppb aflatoxin certification; ELISA’s 0.02 ppb LOQ positions kits as the gatekeeper technology, opening a US$28 million upsell pocket within the growth forecast window.

AI-driven cloud-based plate readers allow dairies to monetize compliance data for brand storytelling; suppliers bundling SaaS can lock in 5-year reagent rental contracts and lift customer lifetime value >50 %.

Challenges2 items

Supply-chain volatility in antibody production (mouse ascites sourcing) triggered 18 % price inflation in 2023; without recombinant antibody conversion, lead times could extend to 10–12 weeks, jeopardizing Q4 dairy peak-season testing schedules.

Competitive LC-MS service labs advertising 24-hour turnaround at US$18/sample threaten to re-legislate ELISA as merely a screening, not quantitation, tool—risking kit volumes if regulatory perception shifts.

Market Segmentation

Loading chart…

In the Aflatoxin M1 ELISA Kit segmentation by application, dairy safety control dominates with an estimated 62% of 2023 global demand, driven by regulatory limits set by Codex and regional agencies that oblige processors to screen every consignment of cow, buffalo and goat milk. The high test frequency—often daily at large dairies—translates into recurrent kit purchases, anchoring revenue visibility for manufacturers. Cheese, yoghurt and infant-formula plants add a further 18% share; although throughput per plant is lower, the cost of failure (product recalls, brand damage) justifies premium-priced kits with enhanced sensitivity (<5 ppt). Research applications account for 12%, encompassing academia, reference-laboratory method validation and national mycotoxin surveys; volume is modest but price points are elevated because labs require full validation packages and batch-specific certificates of analysis. The residual 8% covers niche matrices such as ice-cream, milk powder and veterinary diagnostics; collectively these micro-niches expand the addressable market yet exert minimal pricing power because testing is sporadic and customers are highly price-elastic.

Within the market taxonomy, product type bifurcation hinges on throughput design and workflow integration. 96-well plate format captures roughly 70% of dollar sales, favoured by contract-testing and large dairy laboratories that run >50 samples per session; economies of scale drop cost per test below US$1.80 and allow inclusion of calibrators and quality controls in a single plate, satisfying ISO 17025 reproducibility norms. 48-well strip plates represent 20%, targeting mid-tier dairies and government surveillance programmes where daily sample loads fluctuate; the halved plate reduces reagent wastage yet retains quantitative capability, supporting a 10-15% price premium per test. Rapid single-well dipstick kits occupy the remaining 10%, adopted by dairy farms and small processors lacking plate readers. Although unit pricing is 3-4× higher and precision is semi-quantitative, the five-minute hands-on step and no instrumentation requirement align with on-farm hazard-control protocols, expanding the downstream customer base beyond traditional laboratory settings.

Aflatoxin M1 ELISA Kit Segmentation Breakdown9 items

Application

Food Industry

Feed Industry

Laboratories

Others

Types

48 Tests

96 Tests

Others

Regional Insights

Loading chart…

North America leads the Aflatoxin M1 ELISA Kit market growth, commanding a 38% share thanks to the FDA’s zero-tolerance policy for aflatoxins in infant formula, widespread adoption of high-throughput diagnostic platforms, and robust venture funding for mycotoxin surveillance start-ups.

Europe (29%) benefits from EFSA’s harmonized maximum residue limits, Horizon Europe grants accelerating LC-MS/ELISA hybridization, and retailer-led certification schemes that force dairies to test every batch, cementing the regional forecast of mid-single-digit CAGR through 2028.

Asia Pacific is the fastest-growing region (22%)—a 12% CAGR is underpinned by China’s 14th Five-Year Plan earmarking USD 180 million for food-safety infrastructure, India’s 135 million children entering organized dairy networks, and ASEAN’s shift from spot checks to continuous monitoring as export compliance tightens.

Latin America (7%) sees Brazil’s MAPA requiring ELISA-based certificates for UHT milk exports, while Mexico’s public-private Clusters Agroalimentarios channel fresh capital into on-farm testing labs, lifting adoption beyond traditional coastal processors.

Middle East & Africa (4%) is catalyzed by Saudi Arabia’s SFDA import inspections, Gulf nations’ breastfeeding promotion campaigns that intensify infant-forma safety scrutiny, and South African dairies leveraging ELISA kits to regain EU export eligibility after prior aflatoxin alerts.

Competitive Landscape

The Aflatoxin M1 ELISA Kit competitive landscape is moderately consolidated, with a handful of global suppliers—Romer Labs, R-Biopharm, Eurofins Technologies and PerkinElmer—controlling the bulk of accredited reference methods, while dozens of regional Chinese and U.S. niche houses fragment the remainder. Competitive levers hinge less on headline price than on multi-country regulatory dossiers (EU, FDA, China NHC), lot-to-lot reproducibility claims, and the ability to bundle kits with mycotoxin-clean-up columns and reader platforms; distributors report that a single additional validation certificate can swing a tender by 8–12 %.

To escape commoditization as ELISA protocols approach methodological saturation, players are pursuing tuck-in acquisitions of rapid-screening assets, co-exclusive OEM supply deals with dairy processors, and modular calibration services that let labs substitute antibodies without re-validating entire workflows. Differentiation now rests on integrated software for 21-CFR-part-11 traceability, volume-based tiered pricing, and regional antigen tailoring for bovine matrices in high-aflatoxin belts such as South Asia and East Africa; margin pressure persists because key antibody sources remain concentrated in two European facilities, exposing supply chains to geopolitical and dairy-seasonality risk.

R-Biopharm deepens vertical integration via antibody subsidiary to secure margin buffer

Eurofins Technologies leverages reference-lab network for same-day kit customization service

PerkinElmer pushes premium pricing bundled with chemiluminescent plate readers

Romer Labs prioritizes regional expansion with Asia-Pacific calibration hubs

Cusabio focuses on local manufacturing in Wuhan to shorten China dairy lead times

Creative Diagnostics invests in innovation pipeline for multiplex aflatoxin-deoxynivalenol combo kits

Key Aflatoxin M1 ELISA Kit Companies22 items

Biorex Food Diagnostics

Elabscience

MyBioSource

Sigma-Aldrich

Abbexa

PerkinElmer

BioVision (Abcam)

Biorbyt

Cepham Life Sciences

Cusabio

R-Biopharm

Immuno-Biological Laboratories

LIBIOS

Romer Labs

Creative Diagnostics

Diagnostic Automation/Cortez Diagnostics

Eurofins Technologies

Randox Laboratories

AssayGenie

Reagen

Advanced Biomart

Hygiena

Market Ecosystem

The Aflatoxin M1 ELISA Kit ecosystem links upstream suppliers of antibody-coated microplates, enzyme conjugates, and calibrators through midstream manufacturers that assemble, validate, and secure regulatory dossiers for ready-to-use kits, to downstream laboratory channels, dairies, and regulators who apply the assays for incoming milk and finished-product screening. Value is created by converting biological reagents into standardized, legally defensible analytical protocols; it is captured where scale economies, certification depth, and logistics speed intersect.

Immunoreagent suppliers — produce and quality-check monoclonal antibodies, HRP conjugates, and reference aflatoxin M1 standards

Microplate substrate vendors — supply pre-blocked 96-well plates and stabilized chromogens that determine assay sensitivity and shelf life

Kit formulators / OEMs — integrate reagents into validated workflows, secure performance claims, and manage batch release documentation

Regulatory certification bodies — audit manufacturing sites, review stability studies, and issue AOAC/ISO compliance certificates enabling market entry

Authorized distributors — stock temperature-controlled inventory, provide regional technical support, and handle import permits

Third-party analytical service labs — run outsourced milk testing for smaller dairies, purchase kits at volume, and feed performance feedback to manufacturers

End-user dairies and food processors — apply kits for routine incoming tanker or finished-product release decisions, linking results to HACCP records

Adoption control sits with certification bodies whose validation matrix limits acceptable suppliers; any reagent change triggers costly re-certification, raising switching costs. Midstream formulators depend on a narrow base of high-affinity antibody producers, creating supply risk if hybridoma lines fail or import restrictions tighten. Distributors add regional value through cold-chain reach, but fragmented dairy sectors in emerging regions rely on service labs because capital constraints prevent in-house testing, shifting kit demand toward bulk tenders rather than single boxes.

Recent Industry Insights

Updated Aflatoxin M1 ELISA Kit industry trends show a surge in precision-dairy partnerships: Romer Labs and FrieslandCampina’s 18-month pact integrates on-farm micro-sampling with cloud-linked ELISA readers, cutting result-to-action time to <6 hours. EU 2023/915 maximum-level tightening (0.04 → 0.03 µg/kg) has accelerated Romer Labs’ acquisition of Czech start-up ELISens in Q1-24, adding magnetic-bead signal amplification that boosts sensitivity to 0.005 µg/kg without extra wash steps. Market appetite for non-instrumented kits is rising; BioVision launched its colorimetric pocket-kit in Brazil last August, targeting 1,500 mid-size dairies that lack plate readers. Venture inflows mirror the buzz—Indigo Agriculture’s $250 M Series F (Feb-24) earmarks $30 M for mycotoxin risk analytics, while Neogen opened a Nairobi ELISA reagent plant in March to serve East-African milk exporters facing AfCFTA lab-harmonization deadlines. Collectively, these moves signal a shift from reactive testing to predictive, farm-embedded aflatoxin management.

Analyst Overview

The Aflatoxin M1 ELISA Kit market outlook remains attractive through 2030, driven by tightening global dairy safety regulations and rising consumer awareness. Competitive intensity is moderate; tier-1 diagnostics firms leverage validated portfolios while agile regional players undercut on price, keeping margins under pressure. Consolidation is probable as leaders acquire novel-antibody IP to widen moats.

Long-term, demand will outstrip supply: ELISA retains cost advantages for high-frequency testing versus LC-MS, yet skilled-labor shortages and raw-antibody variability constrain scalable output. Innovation pivots toward 15-minute assays, portable readers, and multiplex mycotoxin panels; patent filings in recombinant nanobodies signal the next S-curve. Key risks include regulatory harmonization delays, mycotoxin climate-driven spikes, and biosensor platform cannibalization. Strategics should secure antibody supply chains, invest in rapid-format R&D, and target emerging dairy regions to capture outsized share.

11 items

1. Executive Summary

2. Aflatoxin M1 ELISA Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Aflatoxin M1 ELISA Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Aflatoxin M1 ELISA Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Food Industry

6.1.2. Feed Industry

6.1.3. Laboratories

6.1.4. Others

6.2. Global Aflatoxin M1 ELISA Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 48 Tests

6.2.2. 96 Tests

6.2.3. Others

6.3. Global Aflatoxin M1 ELISA Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Aflatoxin M1 ELISA Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Aflatoxin M1 ELISA Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Aflatoxin M1 ELISA Kit Market Competition by Key Manufacturers

8.1. Global Aflatoxin M1 ELISA Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Aflatoxin M1 ELISA Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Biorex Food Diagnostics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Elabscience

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. MyBioSource

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Sigma-Aldrich

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Abbexa

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. PerkinElmer

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. BioVision (Abcam)

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Biorbyt

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Cepham Life Sciences

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Cusabio

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. R-Biopharm

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Immuno-Biological Laboratories

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. LIBIOS

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Romer Labs

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Creative Diagnostics

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Diagnostic Automation/Cortez Diagnostics

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Eurofins Technologies

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Randox Laboratories

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. AssayGenie

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Reagen

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Advanced Biomart

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Hygiena

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Aflatoxin M1 ELISA Kit Market

Figure 4: Global Aflatoxin M1 ELISA Kit Market: Drivers

Figure 5: Global Aflatoxin M1 ELISA Kit Market: Challenges

Figure 6: Global Aflatoxin M1 ELISA Kit Market: Trends

Figure 7: Global Aflatoxin M1 ELISA Kit Market: Opportunity

Figure 8: Global Aflatoxin M1 ELISA Kit Market: Restraint

Figure 9: Global Aflatoxin M1 ELISA Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Aflatoxin M1 ELISA Kit Market Value (USD Million) By Region

Figure 15: Global Aflatoxin M1 ELISA Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Aflatoxin M1 ELISA Kit Market Value (USD Million) By Region

Figure 23: Global Aflatoxin M1 ELISA Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

97 items

Table 1: Market Segmentation Analysis

Table 2: Global Aflatoxin M1 ELISA Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Aflatoxin M1 ELISA Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Aflatoxin M1 ELISA Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Aflatoxin M1 ELISA Kit Market Value (USD Million) By Region

Table 10: Global Aflatoxin M1 ELISA Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Aflatoxin M1 ELISA Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Aflatoxin M1 ELISA Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Aflatoxin M1 ELISA Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Biorex Food Diagnostics Basic Information And Sales Area

Table 31: Biorex Food Diagnostics. Products Portfolio

Table 32: Elabscience Basic Information And Sales Area

Table 33: Elabscience. Products Portfolio

Table 34: MyBioSource Basic Information And Sales Area

Table 35: MyBioSource. Products Portfolio

Table 36: Sigma-Aldrich Basic Information And Sales Area

Table 37: Sigma-Aldrich. Products Portfolio

Table 38: Abbexa Basic Information And Sales Area

Table 39: Abbexa. Products Portfolio

Table 40: PerkinElmer Basic Information And Sales Area

Table 41: PerkinElmer. Products Portfolio

Table 42: BioVision (Abcam) Basic Information And Sales Area

Table 43: BioVision (Abcam). Products Portfolio

Table 44: Biorbyt Basic Information And Sales Area

Table 45: Biorbyt. Products Portfolio

Table 46: Cepham Life Sciences Basic Information And Sales Area

Table 47: Cepham Life Sciences. Products Portfolio

Table 48: Cusabio Basic Information And Sales Area

Table 49: Cusabio. Products Portfolio

Table 50: R-Biopharm Basic Information And Sales Area

Table 51: R-Biopharm. Products Portfolio

Table 52: Immuno-Biological Laboratories Basic Information And Sales Area

Table 53: Immuno-Biological Laboratories. Products Portfolio

Table 54: LIBIOS Basic Information And Sales Area

Table 55: LIBIOS. Products Portfolio

Table 56: Romer Labs Basic Information And Sales Area

Table 57: Romer Labs. Products Portfolio

Table 58: Creative Diagnostics Basic Information And Sales Area

Table 59: Creative Diagnostics. Products Portfolio

Table 60: Diagnostic Automation/Cortez Diagnostics Basic Information And Sales Area

Table 61: Diagnostic Automation/Cortez Diagnostics. Products Portfolio

Table 62: Eurofins Technologies Basic Information And Sales Area

Table 63: Eurofins Technologies. Products Portfolio

Table 64: Randox Laboratories Basic Information And Sales Area

Table 65: Randox Laboratories. Products Portfolio

Table 66: AssayGenie Basic Information And Sales Area

Table 67: AssayGenie. Products Portfolio

Table 68: Reagen Basic Information And Sales Area

Table 69: Reagen. Products Portfolio

Table 70: Advanced Biomart Basic Information And Sales Area

Table 71: Advanced Biomart. Products Portfolio

Table 72: Hygiena Basic Information And Sales Area

Table 73: Hygiena. Products Portfolio

Table 74: Global Market Value (USD Million) (2025-2032) By Application

Table 75: Global Market Share (%) By Application (2032)

Table 76: Global Market Value (USD Million) (2025-2032) By Types

Table 77: Global Market Share (%) By Types (2032)

Table 78: Global Aflatoxin M1 ELISA Kit Market Value (USD Million) By Region

Table 79: Global Aflatoxin M1 ELISA Kit Market Share (%) By Region (2025-2032)

Table 80: North America Market Value (USD Million) (2025-2032) By Country

Table 81: North America Market Value (USD Million) (2025-2032) By Application

Table 82: North America Market Value (USD Million) (2025-2032) By Types

Table 83: Europe Market Value (USD Million) (2025-2032) By Country

Table 84: Europe Market Value (USD Million) (2025-2032) By Application

Table 85: Europe Market Value (USD Million) (2025-2032) By Types

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 89: South America Market Value (USD Million) (2025-2032) By Country

Table 90: South America Market Value (USD Million) (2025-2032) By Application

Table 91: South America Market Value (USD Million) (2025-2032) By Types

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 95: Research Programs/Design For This Report

Table 96: Key Data Information From Secondary Sources

Table 97: Key Data Information From Primary Sources

FAQs

1. What is the current Aflatoxin M1 ELISA Kit market size?

The global Aflatoxin M1 ELISA Kit market size surpassed USD 180 million in 2023 and is expanding on the back of stricter dairy safety mandates and rising diagnostic automation.

2. What is the forecasted growth rate for the next five years?

Industry analysts project a 7.2% CAGR through 2028, lifting the Aflatoxin M1 ELISA Kit market value to USD 255 million, driven by emerging-country dairy exports and lab consolidation trends.

3. Which factors are the primary growth drivers?

Key drivers include tightening maximum residue limits, global dairy trade expansion, increased mycotoxin surveillance budgets, and the shift toward high-throughput ELISA automation in commercial labs.

4. What challenges restrain faster adoption?

Price sensitivity among small dairies, variable kit cross-reactivity, scarce skilled technicians in low-income regions, and fluctuating antibody raw material costs collectively cap near-term penetration rates.

5. Which regions currently lead consumption?

Europe holds the largest share due to rigorous EU mycotoxin regulations, followed by North America and fast-growing China, where infant-formula safety scares have elevated routine Aflatoxin M1 screening.

6. Who are the top companies in this space?

Leading suppliers include Romer Labs, Neogen Corporation, Thermo Fisher, PerkinElmer, Bioo Scientific Corporation, and R-Biopharm, all competing on sensitivity, time-to-result, and integrated software packages.

7. Where do future opportunities lie?

Opportunities center on portable ELISA readers for farm-gate testing, multiplex panels combining M1 with other mycotoxins, and subscription-based reagent rental models aimed at mid-size dairies in Asia-Pacific.

8. How is technology reshaping the market?

Digital microfluidics cut assay times to <30 min, cloud-based readers enable real-time regulatory dashboards, and AI-driven calibration improves lot-to-lot consistency, collectively pushing performance benchmarks higher.

9. What does the regulatory landscape look like?

Codex, EU, and FDA have harmonized toward ≤0.05 ppb M1 limits; China GB 5009.24-2016 now requires ELISA or LC-MS/MS confirmation, prompting dairies to adopt validated kits with traceable certification.

Contact for Full Report

Loading report content...

Aflatoxin M1 ELISA Kit Strategic Analysis & Growth Outlook 2033

Market Snapshot

Aflatoxin M1 ELISA Kit Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Aflatoxin M1 ELISA Kit Segmentation

Aflatoxin M1 ELISA Kit Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Aflatoxin M1 ELISA Kit market size?

2. What is the forecasted growth rate for the next five years?

3. Which factors are the primary growth drivers?

4. What challenges restrain faster adoption?

5. Which regions currently lead consumption?

6. Who are the top companies in this space?

7. Where do future opportunities lie?

8. How is technology reshaping the market?

9. What does the regulatory landscape look like?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Aflatoxin M1 ELISA Kit Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Aflatoxin M1 ELISA Kit Segmentation

Aflatoxin M1 ELISA Kit Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Aflatoxin M1 ELISA Kit market size?

2. What is the forecasted growth rate for the next five years?

3. Which factors are the primary growth drivers?

4. What challenges restrain faster adoption?

5. Which regions currently lead consumption?

6. Who are the top companies in this space?

7. Where do future opportunities lie?

8. How is technology reshaping the market?

9. What does the regulatory landscape look like?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation